Org Chart Alzheimer's disease and Hallucinations by harper mcmillan

Source One

hwmcmillan1 — 2024-11-19 19:53:52 UTC

Link:

Citation:

El Haj, M., Roche, J., Jardri, R., Kapogiannis, D., Gallouj, K., & Antoine, P. (2017). Clinical and neurocognitive aspects of hallucinations in Alzheimer’s disease. Neuroscience & Biobehavioral Reviews, 83, 713-720. https://doi.org/10.1016/j.neubiorev.2017.02.021

Source Two

hwmcmillan1 — 2024-11-19 19:54:00 UTC

Link:

Science Direct (again)

Citation:

Donovan, N. J., Wadsworth, L. P., Lorius, N., Locascio, J. J., Rentz, D. M., Johnson, K. A., Sperling, R. A., & Marshall, G. A. (2014). Regional Cortical Thinning Predicts Worsening Apathy and Hallucinations Across the Alzheimer Disease Spectrum. The American Journal of Geriatric Psychiatry, 22(11), 1168-1179. https://doi.org/10.1016/j.jagp.2013.03.006

Frequency of Hallucinations in Alzheimers

hwmcmillan1 — 2024-11-20 19:42:05 UTC

Whilst AD is most well-known for causing memory impairment, such as in my grandmother, patients will also contract hallucinations often, and it is not uncommon for a patient to have hallucinations
Since Alzheimers usually occurs in older people, this may pose a problem to caretakers or companions who want to help them.

Alzheimer's

hwmcmillan1 — 2024-11-21 04:01:22 UTC

Alzheimer’s disease (AD) is a progressive neurodegenerative disease.

This disease has a wide spectrum of effects, having similar results to dementia.
This can be genetically passed down, which means if your mother had Alzheimer's, you might have an increased risk.
The hallmark of AD is progressive episodic memory impairment

ALZHA

hwmcmillan1 — 2024-11-21 04:15:19 UTC

We first describe the prevalence, characteristics, and consequences of hallucinations in the disease, and then provide the currently proposed neurological, genetic, and cognitive and affective explanations. We then proceed to propose a new theoretical framework, which captures the complexity of underlying mechanisms of hallucinations in AD. This framework, named ALZHA (ALZheimer and Hallucinations)dissociates “state” and “trait” markers of hallucinations.

Hemsley

hwmcmillan1 — 2024-11-21 10:01:18 UTC

According to Hemsley (Hemsley, 2005), inhibitory dysfunction lead to the emergence of redundant or irrelevant information from memory into awareness, generating hallucinations

AD Biomarkers

hwmcmillan1 — 2024-11-21 10:52:52 UTC

How are biomarkers associated with apathy and hallucinations in people with Alzheimer's?
Biomarkers can measure levels of apathy and hallucinations. They can also help people determine the difference between two different experiments.

What are the reasons Behind Apathy and Hallucinations in Alzheimer's?

hwmcmillan1 — 2024-11-21 10:55:22 UTC

the less temporal cortical thickness would indicate more apathy.
reduced supramarginal cortical thickness was predictive of increasing hallucinations

What is a CSF biomarker?

hwmcmillan1 — 2024-11-21 10:58:30 UTC

This is a way of measurement that the scientists conducting this test used.
Cerebrospinal fluid (CSF) biomarkers reflect brain pathophysiology
Pathophysiology is basically a way for people to examine brain damage, injuries, or illnesses and the effects that they have on us.